2022 FIC Exhibition

2023.01.16

Bloomage Biotech brought scenario-based solutions to this exhibition, such as oral beauty, bone and joint health, gastrointestinal health, and sleep health. Also, held the"Bloomage Biotech 2022 AbateHP™ New Product Launch Conference" to launch the anti-Helicobacter pylori solution.

Worldwide >85% of gastric cancers are attributed to Helicobacter pylori infection, and China is a high incidence area of Helicobacter pylori infection. As people pay more attention to health, more and more people will actively participate in treatment after being diagnosed with Helicobacter pylori.

At the Bloomage Biotech 2022 AbateHP™ New Product Launch Conference, Bloomage Biotech and many experts from the industry discussed the gastrointestinal market trend, clinical research on Helicobacter pylori infection and the application plan of anti-pylori bioactive substances. With the help of this product technology seminar, Bloomage Biotech hopes to work with industry experts to improve the industry's understanding of Helicobacter pylori and provide more scientific and practical anti-pylori solutions.

In addition to AbateHP™, Bloomage Biotech also fully demonstrated the application of sodium hyaluronate in oral beauty, bone and joint maintenance, intestinal health and other fields.